Suntrust Banks’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $5.37M | Sell |
37,882
-4,234
| -10% | -$600K | 0.03% | 336 |
|
|
2019
Q2 | $5.27M | Buy |
42,116
+448
| +1% | +$56.1K | 0.03% | 338 |
|
|
2019
Q1 | $4.59M | Buy |
41,668
+143
| +0.3% | +$15.8K | 0.02% | 349 |
|
|
2018
Q4 | $4.07M | Buy |
41,525
+1,741
| +4% | +$171K | 0.02% | 350 |
|
|
2018
Q3 | $4.91M | Buy |
39,784
+348
| +0.9% | +$43K | 0.03% | 327 |
|
|
2018
Q2 | $3.92M | Buy |
39,436
+247
| +0.6% | +$24.5K | 0.02% | 371 |
|
|
2018
Q1 | $3.46M | Buy |
39,189
+2,521
| +7% | +$223K | 0.02% | 380 |
|
|
2017
Q4 | $3.62M | Buy |
36,668
+585
| +2% | +$57.7K | 0.02% | 335 |
|
|
2017
Q3 | $3.47M | Buy |
36,083
+25,412
| +238% | +$2.45M | 0.02% | 367 |
|
|
2017
Q2 | $1.01M | Buy |
10,671
+336
| +3% | +$31.7K | 0.01% | 652 |
|
|
2017
Q1 | $843K | Buy |
10,335
+639
| +7% | +$52.1K | 0.01% | 687 |
|
|
2016
Q4 | $821K | Buy |
9,696
+547
| +6% | +$46.3K | ﹤0.01% | 834 |
|
|
2016
Q3 | $679K | Buy |
9,149
+166
| +2% | +$12.3K | ﹤0.01% | 858 |
|
|
2016
Q2 | $680K | Buy |
8,983
+808
| +10% | +$61.2K | ﹤0.01% | 838 |
|
|
2016
Q1 | $565K | Sell |
8,175
-637
| -7% | -$44K | ﹤0.01% | 892 |
|
|
2015
Q4 | $529K | Sell |
8,812
-694
| -7% | -$41.7K | ﹤0.01% | 920 |
|
|
2015
Q3 | $513K | Sell |
9,506
-223
| -2% | -$12K | ﹤0.01% | 868 |
|
|
2015
Q2 | $564K | Buy |
9,729
+204
| +2% | +$11.8K | ﹤0.01% | 815 |
|
|
2015
Q1 | $572K | Buy |
9,525
+395
| +4% | +$23.7K | ﹤0.01% | 789 |
|
|
2014
Q4 | $485K | Buy |
9,130
+727
| +9% | +$38.6K | ﹤0.01% | 820 |
|
|
2014
Q3 | $375K | Buy |
+8,403
| New | +$375K | ﹤0.01% | 1073 |
|
|
2014
Q2 | – | Sell |
-7,279
| Closed | -$318K | – | 1707 |
|
|
2014
Q1 | $318K | Sell |
7,279
-587
| -7% | -$25.6K | ﹤0.01% | 1543 |
|
|
2013
Q4 | $383K | Sell |
7,866
-356
| -4% | -$17.3K | ﹤0.01% | 1391 |
|
|
2013
Q3 | $336K | Buy |
8,222
+46
| +0.6% | +$1.88K | ﹤0.01% | 1427 |
|
|
2013
Q2 | $286K | Buy |
+8,176
| New | +$286K | ﹤0.01% | 1438 |
|